SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept ($VERO) is trending after Madryn Asset Management acquired a 91% stake, fueling intense speculation about a potential short squeeze and privatization. Bulls anticipate massive upside, citing the extremely low public float, while others caution about dilution risks and predict a sharp correction after its significant surge. The community is actively debating whether the dominant ownership will lead to unprecedented price appreciation or a swift return to lower valuations.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending due to its new partnership with World Liberty Financial for USD1 payroll and card integration, significantly expanding its real-world utility in on-chain payments. The community is overwhelmingly bullish, highlighting ZBCN's ISO 20022 and MiCA compliance, upcoming Super App launch, and potential expansion onto major blockchains as catalysts for substantial growth.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is experiencing a sharp downturn, sparking intense debate despite numerous recent analyst upgrades and elevated price targets. The community is split, with bulls calling it a manipulated "buy the dip" opportunity based on strong AI-driven growth in its Axon platform and e-commerce expansion, while bears point to its high valuation, broader tech sector weakness, and potential competition from AI giants in the advertising space.

Wishing Well

WISH Crypto is gaining significant attention as its CoinGecko listing has been processed, generating strong community anticipation for its StockTwits chart to become active. The community is highly bullish on this Solana memecoin's unique deflationary tokenomics, which include monthly burns matching US inflation, and its vision for long-term utility and rewards for dedicated holders. Many perceive WISH as a robust, community-backed movement designed for sustained growth, differentiating it from typical short-term plays.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos (XTZ) is trending as recent developments highlight a "Uranium Tokenization Breakthrough" on its Etherlink L2, which secured a fintech innovation award. This positive catalyst, coupled with expanded staking options and broader altcoin market optimism, is fueling a polarized community debate. Many anticipate significant upside in Real World Assets, while a vocal segment remains bearish, questioning its long-term viability.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending amidst a broad software sector sell-off, fueled by investor concerns about AI's impact on traditional software companies and consistent insider selling. Despite recent strong earnings, cloud growth, and a share buyback, the stock's significant decline to multi-year lows has ignited a community debate between fears of obsolescence and conviction that the market is presenting an oversold, undervalued opportunity.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is gaining strong attention amid robust technicals and optimistic community discussions highlighting its expanding LNG production and strategic market positioning. Traders are eyeing a potential short squeeze fueled by high short interest, while awaiting key legal developments that many believe will further affirm the company's growth trajectory in the global energy landscape.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to significant QNX developments for Software-Defined Vehicles, including foundational partnerships with BMW for its Neue Klasse architecture and Mercedes-Benz integrating Alloy Kore. The community is actively discussing QNX's record revenue and expanded role in mission-critical systems, viewing its deep penetration in the automotive and IoT sectors as a strong long-term catalyst. While many are optimistic about future growth, some express frustration over the overall stock performance and market valuation despite these positive announcements.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending following a recent 1-for-15 reverse stock split and in anticipation of upcoming Phase 3 trial readouts for myelofibrosis and endometrial cancer. However, community discussion is intensely focused on strong dissatisfaction with current management, citing concerns over significant shareholder value destruction, financial discipline, and the company's cash runway. Many believe a change in leadership is essential for any meaningful turnaround, despite the potential positive impact of successful clinical trial data.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing significant market attention following its ANKTIVA drug's accelerated approval by the Saudi FDA for non-small cell lung and bladder cancers, alongside robust preliminary revenue growth for ANKTIVA and promising clinical updates. The community is actively discussing the potential for a substantial short squeeze, driven by unusually high trading volumes and significant short interest, as optimism grows for further regulatory advancements and strategic partnerships in its innovative oncology pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


CVTX
CV Therapeutics, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest CVTX News

CVTXCV Therapeutics, Inc.